TY - JOUR
T1 - Quality of life and mid-term survival of patients bridged with extracorporeal membrane oxygenation to left ventricular assist device
AU - Unai, Shinya
AU - Yamane, Kentaro
AU - Tanaka, Daizo
AU - Cook, Gary
AU - Hirose, Hitoshi
AU - Cavarocchi, Nicholas C.
AU - Entwistle, John W.C.
N1 - Publisher Copyright:
© 2017 by the ASAIO.
PY - 2017/6/1
Y1 - 2017/6/1
N2 - Insertion of a left ventricular assist device (LVAD) improves survival and quality of life (QOL) in patients with class IV heart failure failing medical management, However, QOL and survival of patients bridged to LVAD with extracorporeal membrane oxygenation (ECMO) is unknown, Between July 2008 and June 2014, 213 patients underwent insertion of HeartMate II LVAD at two VAD centers without a bridge with a temporary VAD, Extracorporeal membrane oxygenation was used as a bridge before LVAD insertion in 22 Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients (ECMO-VAD group), No bridge was used in 21 INTERMACS 1 patients and 170 INTERMACS 2-4 patients (primary LVAD group), Survival was compared between the ECMO-VAD group and INTERMACS 1 patients who underwent a primary LVAD insertion (INTERMACS 1 group), Quality of life was compared between the ECMO-VAD group and the primary LVAD group as a whole, The in-hospital mortality of the ECMO-VAD and INTERMACS1 groups was 23% and 14%, respectively (P = 0.38),
AB - Insertion of a left ventricular assist device (LVAD) improves survival and quality of life (QOL) in patients with class IV heart failure failing medical management, However, QOL and survival of patients bridged to LVAD with extracorporeal membrane oxygenation (ECMO) is unknown, Between July 2008 and June 2014, 213 patients underwent insertion of HeartMate II LVAD at two VAD centers without a bridge with a temporary VAD, Extracorporeal membrane oxygenation was used as a bridge before LVAD insertion in 22 Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients (ECMO-VAD group), No bridge was used in 21 INTERMACS 1 patients and 170 INTERMACS 2-4 patients (primary LVAD group), Survival was compared between the ECMO-VAD group and INTERMACS 1 patients who underwent a primary LVAD insertion (INTERMACS 1 group), Quality of life was compared between the ECMO-VAD group and the primary LVAD group as a whole, The in-hospital mortality of the ECMO-VAD and INTERMACS1 groups was 23% and 14%, respectively (P = 0.38),
UR - http://www.scopus.com/inward/record.url?scp=84995812338&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995812338&partnerID=8YFLogxK
U2 - 10.1097/MAT.0000000000000471
DO - 10.1097/MAT.0000000000000471
M3 - Article
C2 - 27861427
AN - SCOPUS:84995812338
SN - 1058-2916
VL - 63
SP - 273
EP - 278
JO - ASAIO Journal
JF - ASAIO Journal
IS - 3
ER -